Related Experiment Videos

Emerging resistance in clinically important gram-positive cocci

C Thornsberry1

  • 1MRL Pharmaceutical Services, Franklin, TN 37064, USA.

Insights

Antimicrobial resistance in gram-positive bacteria is rising in the US. Key pathogens like Staphylococcus aureus and Streptococcus pneumoniae show increasing resistance, posing significant public health challenges.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • The early 1990s witnessed a significant rise in antimicrobial resistance among key gram-positive cocci in the United States.
  • This trend impacts medically important bacteria, necessitating urgent attention to treatment strategies and resistance monitoring.

Purpose of the Study:

  • To document the escalating antimicrobial resistance patterns in prevalent gram-positive bacterial pathogens in the US during the early 1990s.
  • To highlight the increasing incidence of multidrug-resistant strains.

Main Methods:

  • Surveillance of antimicrobial susceptibility testing data for gram-positive cocci.
  • Analysis of resistance trends for specific pathogens including Staphylococcus aureus, Enterococcus faecium, and Streptococcus pneumoniae.

Main Results:

  • Methicillin resistance in Staphylococcus aureus increased to 18%, with a rise in multiply resistant isolates.
  • Enterococcus faecium demonstrated increasing resistance to penicillin, gentamicin, streptomycin, and vancomycin, with plasmid-mediated vancomycin resistance noted.
  • Over 25% of Streptococcus pneumoniae strains exhibited penicillin resistance, often accompanied by resistance to cephalosporins and macrolides.

Conclusions:

  • The early 1990s marked a critical period of escalating antimicrobial resistance in common gram-positive pathogens in the US.
  • The emergence of multidrug-resistant strains necessitates enhanced surveillance and the development of novel therapeutic approaches.

Related Concept Videos